UBS Group
CLX icon

UBS Group’s Clorox CLX Stock Holding History

UBS Group’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-104,500
Closed -$10.5M – 10575
2025
Q4 		$10.5M Buy
+104,500
New +$11.3M ﹤0.01% 3228
2025
Q3 		– Sell
-5,000
Closed -$600K – 10388
2025
Q2 		$600K Buy
5,000
+400
+9% +$53.4K ﹤0.01% 5860
2025
Q1 		$677K Buy
+4,600
New +$702K ﹤0.01% 5604
2024
Q1 		– Sell
-43,000
Closed -$6.13M – 9393
2023
Q4 		$6.13M Buy
+43,000
New +$5.73M ﹤0.01% 2557
2021
Q1 		– Sell
-17,800
Closed -$3.59M – 9033
2020
Q4 		$3.59M Buy
17,800
+9,300
+109% +$1.92M ﹤0.01% 2802
2020
Q3 		$1.79M Buy
+8,500
New +$1.89M ﹤0.01% 3148
2017
Q1 		– Sell
-100
Closed -$12K – 7673
2016
Q4 		$12K Hold
100
– – ﹤0.01% 6807
2016
Q3 		$13K Sell
100
-1,600
-94% -$210K ﹤0.01% 6594
2016
Q2 		$236K Hold
1,700
– – ﹤0.01% 4443
2016
Q1 		$214K Buy
1,700
+1,500
+750% +$191K ﹤0.01% 4446
2015
Q4 		$25K Sell
200
-5,000
-96% -$621K ﹤0.01% 6507
2015
Q3 		$601K Buy
5,200
+5,000
+2,500% +$561K ﹤0.01% 3741
2015
Q2 		$21K Sell
200
-900
-82% -$97.1K ﹤0.01% 6819
2015
Q1 		$121K Sell
1,100
-10,400
-90% -$1.13M ﹤0.01% 5271
2014
Q4 		$1.2M Buy
+11,500
New +$1.15M ﹤0.01% 3416

Other funds holding CLX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

UBS Group's CLX Position: Q1 2026 in Review

UBS Group increased its Clorox (CLX) stake by 7.5% in Q1 2026, buying an estimated $7.2M and bringing the position to 914,364 shares worth $94.8M. The position accounts for 0.01% of the portfolio, ranked #1098.

UBS Group first reported a position in CLX in Q4 2014 and has held it in 46 quarters since. The position peaked at $216M in Q2 2025. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • UBS Group held 914,364 shares of Clorox worth $94.8M as of Q1 2026.
  • UBS Group bought 63,550 Clorox shares in Q1 2026, an estimated $7.2M.
  • Clorox made up 0.01% of UBS Group's portfolio in Q1 2026, its #1098 holding.
  • UBS Group first reported a position in Clorox in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Clorox position peaked at $216M in Q2 2025.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.